Dr. James Utley with AABB Staff Member at their 2023 Conference
Auragens has sought out oversight from the top local and International governing bodies. We do this to ensure we maintain third party verification of safety and quality of both our biologics and our administration. As we continue to produce evidenced based results, publish in renowned medical journals, and further the art of the possible in the regenerative medicine field, we feel strongly that submitting our work to top accrediting bodies allows us to state confidently that we are at the top of the field.
It is one thing for potential research and academic partners to review our patients results and reach their own incredibly positive conclusions. But it is quite an important layer that we add in to show we have reached the results having accomplished this under the guidance, restrictions, oversight, and knowledge of independent regulatory bodies.
As Auragens currently heads to Houston, TX for this week’s AABB Conference, where our Chief Scientist, Dr. James Utley, will be speaking on a panel, and Auragens will be presenting a paper authored by Dr. Utley and our CEO, Dr. Daniel Briggs, and published in the newest AABB Journal, we felt it was an appropriate time to explain who the AABB is and provide context.
AABB: Advancing Standards in Transfusion Medicine and Cellular Therapies
The Association of Advancement of Blood & Biotherapies (AABB) is a non-profit organization that primarily focuses on advancing the practice and standards of transfusion medicine and cellular therapies. Their work covers a range of areas related to blood and tissue management, cellular therapies, and regenerative medicine, among other things.
The AABB is highly respected both in the U.S. and internationally. Its accreditation and standards are considered benchmarks of quality in the fields of blood banking, transfusion medicine, and cellular therapies, including stem cell treatments. Several factors contribute to its strong reputation:
1️⃣ Rigorous Standards: The AABB sets comprehensive, science-based standards for the collection, processing, testing, and storage of blood, blood components, and cellular therapies. These standards are often adopted by regulatory bodies and other organizations around the world
2️⃣ Accreditation: AABB’s accreditation is recognized as a mark of excellence. Many hospitals, blood banks, and stem cell facilities seek AABB accreditation to demonstrate their commitment to high safety and quality standards.
3️⃣ Collaboration with Regulatory Agencies: The AABB works closely with government and international health agencies like the U.S. FDA, the Centers for Disease Control and Prevention (CDC), and the World Health Organization (WHO). This close relationship helps ensure that their standards align with regulatory requirements.
4️⃣ Global Influence: AABB accreditation and standards are not just limited to the U.S. but are respected globally. Many countries follow their guidelines for blood transfusion and cellular therapies, particularly in terms of safety and ethical practices.
5️⃣ Commitment to Innovation: AABB is forward-looking and continuously updates its standards based on emerging scientific evidence and technological advancements, keeping it at the forefront of developments in transfusion medicine and cellular therapies, including regenerative medicine.
AABB’s primary areas of oversight include:
1️⃣ Blood Banking and Transfusion Services: AABB sets standards for the collection, testing, processing, storage, and distribution of blood and blood components to ensure safety and quality.
2️⃣ Cellular Therapies: They oversee standards for the collection, processing, and storage of cellular therapies, including stem cell treatments, cord blood banking, and other regenerative medicine applications.
3️⃣ Accreditation: AABB provides accreditation to facilities involved in transfusion medicine and cellular therapies, ensuring they meet the organization’s rigorous standards for safety, efficacy, and ethical practices.
4️⃣ Education and Research: AABB also provides education, training, and resources to medical professionals and supports research in fields related to blood and cellular therapies.
Dr. Carlos Diaz, Auragens Chief Medical Officer
